Lonza to build new US factory; Samsung Bio signs $262M contract

Lonza breaks ground on an Oregon spray-drying plant, Samsung Bio lands a $262M deal, and Boston Scientific restores supply post-cyberattack. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in…

Anna Brown · 2026-09-10

Plus, news about Boston Scientific. Lonza’s new factory in the US: Lonza is expanding its US capacity with a new commercial spray-drying facility in Bend, OR. The new build is ...

Source: Endpoints News